Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The study published today (Aug. 9) in the journal ACS Nano. Odom is the Charles E. and Emma H. Morrison Professor of Chemistry in Northwestern’s Weinberg College of Arts and Sciences.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
Learn more: Nanoparticles’ movement reveals whether they can successfully target cancer
The Latest on: Drug-delivery nanoparticles
[google_news title=”” keyword=”drug-delivery nanoparticles” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug-delivery nanoparticles
- Improving Gene Therapy for Lung Diseaseon May 8, 2024 at 5:59 am
Drug delivery researchers at Oregon State University have created a device that could enhance gene therapy for patients with inherited lung diseases like cystic fibrosis, according to a study led by ...
- Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung diseaseon May 7, 2024 at 7:14 am
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
- Nanotechnology in Therapeuticson May 6, 2024 at 4:59 pm
Nanomedicine. 2012;7(8):1253-1271. Although passive targeting approaches form the basis of clinical therapy, they suffer from several limitations. Ubiquitously targeting cells within a tumor is ...
- Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drugon May 4, 2024 at 5:00 pm
Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, ...
- Nanotechnology in Therapeuticson May 2, 2024 at 5:00 pm
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Penn bioengineering professor develops lipid nanoparticles to deliver mRNA inside human cellson April 29, 2024 at 12:47 am
Mitchell leads a biomaterials and drug delivery lab at Penn Engineering that works on engineering new biomaterials, such as lipid nanoparticles.
- Cow's milk particles unlock one of medicine’s most challenging puzzleson April 26, 2024 at 12:47 am
Cow’s milk contains nanoparticles that can be used to deliver disease-modifying RNA therapy orally, according to a new study. With RNA-based drugs currently only administrable by injection, the ...
- Ultrasensitive photonic crystal detects single particles down to 50 nanometerson April 24, 2024 at 12:49 pm
Using an ultrasensitive photonic crystal, TU/e researchers were able to detect single particles down to 50 nanometers in diameter. The new research has just been published in the journal Optica.
- Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technologyon April 18, 2024 at 5:00 pm
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical ...
- Polymeric Nanoparticles: Versatile Carriers for Drug Delivery and Beyondon April 10, 2024 at 9:19 am
The synthesis of polymeric nanoparticles involves various techniques, such as: Polymeric nanoparticles are extensively used as drug delivery vehicles for various therapeutic agents, such as small ...
via Bing News